MCK Q1 growth and Precision Medicine Group acquisition lift outlook
MCK cited strong Q1 growth across key segments, with AI and automation driving productivity. Strategy highlights oncology/biopharma/supply chain and the $2.25B Precision Medicine Group acquisition.